In this study, we revealed upregulation of PARP1 as a mechanism that rendered oral cancer cells resistant to treatment, and PARPi as effective agents that re-sensitized these cells to chemotherapy in vitro and in vivo. The gene discussed is PARP1; the disease is lip and oral cavity carcinoma.